全文获取类型
收费全文 | 123982篇 |
免费 | 8401篇 |
国内免费 | 554篇 |
专业分类
耳鼻咽喉 | 1323篇 |
儿科学 | 3657篇 |
妇产科学 | 2072篇 |
基础医学 | 16568篇 |
口腔科学 | 2212篇 |
临床医学 | 12226篇 |
内科学 | 26205篇 |
皮肤病学 | 1496篇 |
神经病学 | 12093篇 |
特种医学 | 3825篇 |
外国民族医学 | 1篇 |
外科学 | 17817篇 |
综合类 | 1707篇 |
现状与发展 | 1篇 |
一般理论 | 156篇 |
预防医学 | 10802篇 |
眼科学 | 3314篇 |
药学 | 8883篇 |
1篇 | |
中国医学 | 282篇 |
肿瘤学 | 8296篇 |
出版年
2023年 | 568篇 |
2022年 | 898篇 |
2021年 | 2384篇 |
2020年 | 1418篇 |
2019年 | 2417篇 |
2018年 | 2815篇 |
2017年 | 2047篇 |
2016年 | 2390篇 |
2015年 | 2753篇 |
2014年 | 3975篇 |
2013年 | 5592篇 |
2012年 | 8519篇 |
2011年 | 9152篇 |
2010年 | 4996篇 |
2009年 | 4659篇 |
2008年 | 8063篇 |
2007年 | 8579篇 |
2006年 | 8123篇 |
2005年 | 8177篇 |
2004年 | 7721篇 |
2003年 | 7124篇 |
2002年 | 6865篇 |
2001年 | 1229篇 |
2000年 | 924篇 |
1999年 | 1276篇 |
1998年 | 1462篇 |
1997年 | 1245篇 |
1996年 | 963篇 |
1995年 | 962篇 |
1994年 | 814篇 |
1993年 | 799篇 |
1992年 | 689篇 |
1991年 | 631篇 |
1990年 | 565篇 |
1989年 | 519篇 |
1988年 | 522篇 |
1987年 | 501篇 |
1986年 | 432篇 |
1985年 | 510篇 |
1984年 | 580篇 |
1983年 | 534篇 |
1982年 | 702篇 |
1981年 | 614篇 |
1980年 | 536篇 |
1979年 | 386篇 |
1978年 | 358篇 |
1977年 | 354篇 |
1976年 | 297篇 |
1975年 | 284篇 |
1974年 | 293篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Evelyne Harkemanne Jean‐Louis Dargent Pierre‐Paul Roquet‐Gravy Audrey Bulinckx 《Pediatric dermatology》2019,36(3):365-367
We report a case of benign lymphoplasmacytic plaque (LPP) in a child. These asymptomatic erythematous papulonodular lesions are an emerging clinicopathological entity. Herein, we describe a previously unreported site for LPP lesions, namely, the volar wrist and the distal ipsilateral palm. 相似文献
4.
Breanne E. Kunstler Jill L. Cook Joanne L. Kemp Paul D. O’Halloran Caroline F. Finch 《Journal of Science and Medicine in Sport》2019,22(1):2-10
Objectives
To determine: (i) the behaviour change techniques used by a sample of Australian physiotherapists to promote non-treatment physical activity; and (ii) whether those behaviour change techniques are different to the techniques used to encourage adherence to rehabilitation exercises.Design
Cross-sectional survey.Method
An online self-report survey was advertised to private practice and outpatient physiotherapists treating patients with musculoskeletal conditions. The use of 50 behaviour change techniques were measured using five-point Likert-type scale questions.Results
Four-hundred and eighty-six physiotherapists responded to the survey, with 216 surveys fully completed. Most respondents (85.1%) promoted non-treatment physical activity often or all of the time. Respondents frequently used 29 behaviour change techniques to promote non-treatment physical activity or encourage adherence to rehabilitation exercises. A similar number of behaviour change techniques was frequently used to encourage adherence to rehabilitation exercises (n = 28) and promote non-treatment physical activity (n = 26). Half of the behaviour change techniques included in the survey were frequently used for both promoting non-treatment physical activity and encouraging adherence to rehabilitation exercises (n = 25). Graded tasks was the most, and punishment was the least, frequently reported technique used to promote non-treatment physical activity and encourage adherence to rehabilitation exercises.Conclusions
Respondents reported using similar behaviour change techniques to promote non-treatment physical activity and encourage adherence to rehabilitation exercises. The variability in behaviour change technique use suggests the behaviour the physiotherapist is promoting influences their behaviour change technique choice. Including the frequently-used behaviour change techniques in non-treatment physical activity promotion interventions might improve their efficacy. 相似文献5.
6.
7.
8.
Weiyu Ye Anna Olsson-Brown Robert A. Watson Vincent T. F. Cheung Robert D. Morgan Isar Nassiri Rosalin Cooper Chelsea A. Taylor Umair Akbani Oliver Brain Rubeta N. Matin Nicholas Coupe Mark R. Middleton Mark Coles Joseph J. Sacco Miranda J. Payne Benjamin P. Fairfax 《British journal of cancer》2021,124(10):1661
Background Immune checkpoint blockers (ICBs) activate CD8+ T cells, eliciting both anti-cancer activity and immune-related adverse events (irAEs). The relationship of irAEs with baseline parameters and clinical outcome is unclear.Methods Retrospective evaluation of irAEs on survival was performed across primary (N = 144) and secondary (N = 211) independent cohorts of patients with metastatic melanoma receiving single agent (pembrolizumab/nivolumab—sICB) or combination (nivolumab and ipilimumab—cICB) checkpoint blockade. RNA from pre-treatment and post-treatment CD8+ T cells was sequenced and differential gene expression according to irAE development assessed.Results 58.3% of patients developed early irAEs and this was associated with longer progression-free (PFS) and overall survival (OS) across both cohorts (log-rank test, OS: P < 0.0001). Median survival for patients without irAEs was 16.6 months (95% CI: 10.9–33.4) versus not-reached (P = 2.8 × 10−6). Pre-treatment monocyte and neutrophil counts, but not BMI, were additional predictors of clinical outcome. Differential expression of numerous gene pathway members was observed in CD8+ T cells according to irAE development, and patients not developing irAEs demonstrating upregulated CXCR1 pre- and post-treatment.Conclusions Early irAE development post-ICB is associated with favourable survival in MM. Development of irAEs is coupled to expression of numerous gene pathways, suggesting irAE development in-part reflects baseline immune activation.Subject terms: Immunotherapy, Melanoma 相似文献
9.
10.